NasdaqCM:CELCBiotechs
A Look At Celcuity (CELC) Valuation As Chip Romp Joins The Board Ahead Of Potential Gedatolisib Launch
Celcuity (CELC) has appointed Charles R. “Chip” Romp to its Board of Directors, a move focused on commercial experience as the company prepares for the potential approval and launch of gedatolisib.
See our latest analysis for Celcuity.
Celcuity’s latest share price of US$104.51 comes after a 12.76% 90 day share price return and a 1 year total shareholder return that is more than 7x. However, more recent 1 month weakness suggests some momentum has cooled as investors weigh recent board changes...